Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

CytoTherapeutics and Genentech sign new CNS therapeutics agreement

Nov. 29, 1996

Vertex compound effective in rat model of nerve injury

Nov. 29, 1996

New serotoninergic drugs from E. Merck

Nov. 29, 1996

Merck & Co. describes new compounds for dopamine-related disorders

Nov. 29, 1996

Zeneca submits antimigraine Rx for approval

Nov. 28, 1996

Novel anticonvulsant described by SmithKline Beecham

Nov. 28, 1996

First approval for Aricept

Nov. 27, 1996

Fujisawa antidementia agent in clinical stage

Nov. 27, 1996

Initial human safety studies completed for CoCensys' stroke drug

Nov. 27, 1996

Ebselen on track for NDA filing in Japan

Nov. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...